Shuttle Pharmaceuticals

(NASDAQ) SHPH

Current Price$3.40

Market Cap$2.28M

Since IPO (2022)-100%

5 YearN/A

1 Year-91%

1 Month-32%

Shuttle Pharmaceuticals Financials at a Glance

Market Cap

$2.28M

Revenue (TTM)

$0.00

Net Income (TTM)

-$10.82M

EPS (TTM)

-$60.62

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$3.40

Volume

7,003

Open

$3.52

Price

$3.40

Volume

7,003

Open

$3.52

Previous Close

$3.40

Daily Range

$3.40 - $3.87

52-Week Range

$2.90 - $55.90

Estimated Earnings Date

May 14, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$3.40

Volume

7,003

Open

$3.52

Previous Close

$3.40

Daily Range

$3.40 - $3.87

52-Week Range

$2.90 - $55.90

Estimated Earnings Date

May 14, 2026

SHPH News

healthcare lab treatment research scientist

Why Shares of Shuttle Pharmaceuticals Jumped 160.4% This Week

James HalleySep 9, 2022

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shuttle Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Christopher Robert Cooper, MBA

Website

www.shuttlepharma.com

Headquarters

Gaithersburg, MD 20850, US

SHPH Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-408.33%

Return on Capital

-479.24%

Return on Assets

-91.63%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.28M

Shares Outstanding

637.10K

Volume

7.00K

Avg. Volume

849.10K

Financials (TTM)

Gross Profit

-$922.41K

Operating Income

-$11.18M

EBITDA

-$9.83M

Operating Cash Flow

-$9.37M

Capital Expenditure

$4.00

Free Cash Flow

-$9.37M

Cash & ST Invst.

$1.09M

Total Debt

$214.01K

Shuttle Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$633.34K

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.28M

N/A

Market Cap/Employee

$253.42K

N/A

Employees

N/A

Net Income

-$2.15M

+29.5%

EBITDA

-$1.51M

+50.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$1.09M

-75.8%

Total Debt

$214.01K

-80.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$134.05K

-39.1%

Short Term Debt

$79.96K

-91.0%

Return on Assets

-91.63%

N/A

Return on Invested Capital

-3.19%

N/A

Free Cash Flow

-$2.42M

+4.3%

Operating Cash Flow

-$2.42M

+4.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BBLGBone Biologics Corporation

BBLGBone Biologics Corporation$1.42+1.43%

RDHLRedHill Biopharma Ltd.

RDHLRedHill Biopharma Ltd.$0.81-2.13%

UPCUniverse Pharmaceuticals Inc.

UPCUniverse Pharmaceuticals Inc.$6.32+13.67%

IMCCIM Cannabis Corp.

IMCCIM Cannabis Corp.$0.15-1.35%

AKANAkanda Corp.

AKANAkanda Corp.$12.33-9.47%

ISPCiSpecimen Inc.

ISPCiSpecimen Inc.$2.64-3.30%

MSPRMSP Recovery, Inc.

MSPRMSP Recovery, Inc.$0.02+58.73%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

INTCIntel

INTCIntel$120.35-0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

Questions About SHPH

What is the current price of Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals is trading at $3.40 per share.

What is the 52-week range for Shuttle Pharmaceuticals?

Over the past 52 weeks, Shuttle Pharmaceuticals has traded between $2.90 and $55.90.

How much debt does Shuttle Pharmaceuticals have?

As of the most recent reporting period, Shuttle Pharmaceuticals reported total debt of $214.01K.

How much cash does Shuttle Pharmaceuticals have on hand?

Shuttle Pharmaceuticals reported $1.09M in cash and cash equivalents in its most recent financial results.

What is Shuttle Pharmaceuticals’s dividend yield?

Shuttle Pharmaceuticals does not currently have a dividend yield.

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Financials at a Glance

SHPH News

Why Shares of Shuttle Pharmaceuticals Jumped 160.4% This Week

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Shuttle Pharmaceuticals

SHPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Shuttle Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SHPH

What is the current price of Shuttle Pharmaceuticals?

What is the 52-week range for Shuttle Pharmaceuticals?

How much debt does Shuttle Pharmaceuticals have?

How much cash does Shuttle Pharmaceuticals have on hand?

What is Shuttle Pharmaceuticals’s dividend yield?

Premium Investing Services